<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1502">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01926600</url>
  </required_header>
  <id_info>
    <org_study_id>24 hour pH</org_study_id>
    <nct_id>NCT01926600</nct_id>
  </id_info>
  <brief_title>Sublingual Administration of PPI</brief_title>
  <official_title>Sublingual Administration is More Fast Than Oral or IV Administration in PPI Dosing With Respect to Intragastric pH and Therapeutic Effectiveness: a Prospective, Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Catholic University of Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Catholic University of Korea</source>
  <oversight_info>
    <authority>Korea: Ministry for Health, Welfare and Family Affairs</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare 24-hour intragastric pH and therapeutic effectiveness of proton pump inhibitor (PPI)
      among different administration methods: per oral (PO), intravenous (IV), and sublingual
      (SL).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Intragastric pH and therapeutic effectiveness of PPI was compared among patients given PPI
      with different administration methods. 24 hour intragastric pH catheter was inserted in
      stomach of patients with peptic ulcer an hour prior to PPI administration in order to
      observe the initial change in pH. Three groups of patients were given PPI through per oral,
      intravenous, and sublingual administration methods. The hypothesis of this study is that
      sublingual administration will be faster than oral or IV administration in PPI dosing with
      respect to intragastric pH change and re-bleeding rate.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Measure 24-hour intragastric pH</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Gastric or Duodenal Ulcer</condition>
  <arm_group>
    <arm_group_label>PO</arm_group_label>
    <description>administrated by per oral</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV</arm_group_label>
    <description>Administrated by intravenous</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SL</arm_group_label>
    <description>administrated by sublingual</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        3 groups, each group with 20 subject with peptic ulcer ages between 20 to 75
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with peptic ulcer disease

          -  Age: 20-75 years old

          -  Patients who submitted informed consent

        Exclusion Criteria:

          -  Peptic ulcer disease with spurting and oozing

          -  Shock, hypotension, pregnancy

          -  Gastrointestinal malignancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jin Il Kim, MD</last_name>
    <phone>82-2-3779-1519</phone>
    <email>jikim@catholic.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>St.Mary's Hopspital of the Catholic University</name>
      <address>
        <city>Seoul</city>
        <zip>150-713</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin Il Kim, MD</last_name>
      <phone>82-2-3779-1519</phone>
      <email>jikim@catholic.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 20, 2013</lastchanged_date>
  <firstreceived_date>August 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Catholic University of Korea</investigator_affiliation>
    <investigator_full_name>Jin Il Kim</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>gastric ulcer</keyword>
  <keyword>duodenal ulcer</keyword>
  <keyword>re-bleeding rate</keyword>
  <keyword>intragastric pH</keyword>
  <keyword>proton pump inhibitor</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Duodenal Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Proton Pump Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
